chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a molecular biology student, who obtained the information from a Vaccine Adverse Event Reporting System (VAERS) report, concerning 235 patients of unknown age and gender. No pertinent medical history, drug reactions, allergies or concurrent conditions were reported. On unknown dates, the patients were vaccinated with unspecified doses of GARDASIL (strength, dosage schedule, route, anatomical location, lot number and expiration date were not reported). Other suspect and concomitant medications were not provided. On unknown dates, the patients died. The causes of death were unknown, and it was also unknown whether autopsies were performed. The reporter indicated that he read the deaths were related to GARDASIL and he was concerned about the number of deaths reported for GARDASIL products. Upon internal review, death was determined to be medically significant. Additional information has been requested.
hives, they have just kept getting worse, mainly on her arms, her head; some pustules in certain spots; the Pfizer Covid booster she had on Monday morning; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 75 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 29Nov2021 (Lot number: FD6809) at the age of 75 years as dose 3 (booster) , single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose-1, Expire date-2Jun2021, Anatomical location -unknown, Lot Number-EN6203), administration date: 02Mar2021, when the patient was 75 years old, for Covid-19 immunization; Bnt162b2 (Dose-2, Expire date-unknown, Anatomical location -left arm, Lot Number-EN6208), administration date: 23Mar2021, when the patient was 75 years old, for Covid-19 immunization; Influenza vaccine (Yes, Caller states she had the influenza vaccine three weeks before the booster on 29Nov2021.), administration date: Nov2021, when the patient was 75 years old, for immunization. The following information was reported: IMMUNISATION (non-serious) with onset 29Nov2021, outcome "unknown", described as "the Pfizer Covid booster she had on Monday morning"; URTICARIA (non-serious) with onset 01Dec2021, outcome "not recovered", described as "hives, they have just kept getting worse, mainly on her arms, her head"; PUSTULE (non-serious) with onset 01Dec2021, outcome "not recovered", described as "some pustules in certain spots". Therapeutic measures were taken as a result of urticaria, pustule.  Follow-up attempts are completed. No further information is expected.
Colleague was fully vaccinated and tested positive for COVID on 24Aug; Colleague was fully vaccinated and tested positive for COVID on 24Aug; This is a spontaneous report from a contactable other hcp. A 53-years-old female patient received first dose bnt162b2 (BNT162B2, Solution for injection, Batch/Lot Number: EN5318) via intramuscular route of administration in Arm Left on 27Jan2021 (age at vaccination:53 Years) as DOSE 1, SINGLE, second dose bnt162b2 (BNT162B2,Solution for injection, Batch/Lot Number: EN5318) via intramuscular route of administration in Arm Left on 17Feb2021 (age at vaccination:53 Years)as DOSE 2, SINGLE for COVID-19 immunisation. Patient was not pregnant at the time of vaccination. The patient medical history and concomitant medications were not reported. On 24Aug2021 the patient experienced colleague was fully vaccinated and tested positive for covid on 24aug, colleague was fully vaccinated and tested positive for covid on 24aug. Treatment received for the events was reported as unknown. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on 24Aug2021 Nasal Swab. The outcome of the events vaccination failure, covid-19 was unknown.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Based on the information available the lack of efficacy of the vaccine BNT162B2 cannot be excluded.
A few days after first shot, noticed numbness in left little toe which progressed to 3,4,5 digits. After second dose (1-2days later) numbness extended to both feet, all digits, soles, and outside foot
Sore upper arm where vaccine was given. Hasn't resolved over time. Pt would like to see MD to examine sore arm (left) since October 3rd.
1) Strong metal taste in mouth for several days. 2) Sore/Tired. 3) My heart was pounding so hard it made me light headed. This lasted for a few days.
Systemic: Abdominal Pain-Mild, Systemic: Dizziness / Lightheadness-Mild, Systemic: face was not swollen but very red-Mild, Systemic: Flushed / Sweating-Mild, Systemic: Tachycardia-Mild
mild pain at the injection site; tiredness; chills; headache; feeling unwell; This is a spontaneous report from a contactable nurse (patient). A 53-year-old female patient received bnt162b2 (BNT162B2; Pfizer-Biontech Covid-19 Vaccine also reported as vaccine A (Pfizer Ultracold); lot number: EH9899; expiration date: unknown), via an unspecified route of administration left arm on 22Dec2020 09:15 at a single dose for covid-19 vaccination. Medical history included anxiety and depression. The patient has no allergies to medications, food, or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient had other medications received within 2 weeks of vaccination. The patient most recent COVID-19 vaccine was administered a hospital. It was reported that 7 hours after vaccination (22Dec2020 04:15 PM [reported as 04:00PM]), the patient experienced mild pain at the injection site, tiredness, chills, headache, and feeling unwell. All resolved within 12 hours after sleep (23Dec2020 04:15). The patient was not diagnosed with COVID-19 prior to vaccination and has not been tested for COVID-19 since the vaccination. The outcome of the events was recovered on 23Dec2020 04:15.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a patient of unknown demographics. No information was provided regarding concomitant medications, concurrent conditions or medical history. On an unknown date in 2010, the patient was inoculated with ZOSTAVAX by a healthcare provider as recommended for permanent prevention and protection against shingles and zoster-related conditions (dose, route, lot # and expiry date was not provided). On an unknown date, the patient was diagnosed with shingles and/or zoster related injuries after and despite being inoculated with ZOSTAVAX vaccine and suffered serious mental and physical pain and suffering and required extensive medical care and treatment. On or about 2016, the patient was treated by a healthcare provider for shingles. As a direct and proximate result of the ZOSTAVAX, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; lost wages; loss of earnings capacity; and other losses and damages. Outcome of the events was unknown. The lawyer assessed the causality was related to ZOSTAVAX.
No adverse event reported. I am reporting a vaccine administration error. The minimum interval had not been met between completion of the primary series and the administration of the bivalent booster dose. Last dose of primary series was 1/30/23. The bivalent booster was administered 2/24/23. Contacted Pfizer to report and find out if dose needs to be repeated. Recommendation was to wait 8 weeks after invalid dose and repeat the bivalent booster. Patient will be contacted regarding this information.
Approximately 12 hours after the immunization, I developed high fever (!03.4), I also had a bad headache I suffered severe weakness, so bad it was hard to get out of bed. I couldn't make it to the bathroom in time and I was incontinent of urine. I took Ibuprofen at 11:30 PM and 3:30 AM. My fever, was 102.7, 102.2, 102.4, 101, 101.5, and currently 100.3. I am sweating a lot at present, but I am feeling so much better now.
within one minute, cough, wheezing, SOB resolved with inhaler.  no EPI pen necessary
not feel well; flu-like symptoms; tiredness; headaches; muscle pain; upset stomach; vomiting; Muscle problem on leg; sore arm; dizziness; vertigo; Vertigo condition aggrevated; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 79-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles. Previously administered products included Zostavax (received on an unknown date). Concurrent medical conditions included vertigo.   On 25th May 2019, the patient received the 1st dose of Shingrix. In May 2019, less than a week after receiving Shingrix, the patient experienced dizziness, vertigo and condition aggravated. On 25th May 2019, the patient experienced pain in arm. On 26th May 2019, the patient experienced feeling unwell, influenza-like symptoms, tiredness, headache, muscle pain, upset stomach, vomiting and muscle disorder. On 26th May 2019, the outcome of the pain in arm was recovered/resolved. On an unknown date, the outcome of the feeling unwell, influenza-like symptoms, tiredness, headache, muscle pain, upset stomach, condition aggravated and muscle disorder were unknown and the outcome of the vomiting, dizziness and vertigo were not recovered/not resolved.   It was unknown if the reporter considered the pain in arm, feeling unwell, influenza-like symptoms, tiredness, headache, muscle pain, upset stomach, vomiting, dizziness, vertigo, condition aggravated and muscle disorder to be related to Shingrix.  Additional details were provided as follows: On 25th May 2019, less than a day after receiving Shingrix, the Patient experienced sore arm which resolved the next day from the first dose. On 26h May 2019, 1 day after receiving Shinrix vaccine, the patient began experiencing flu-like symptoms and she slept and was not feeling well. She stated her flu-like symptoms also included tiredness, headaches, muscle pain, upset stomach, vomiting. The patient also mentioned a muscle problem  on her leg.  The patient also experienced dizziness and vertigo began a couple of days after the flu-like symptoms.   The patient has pre-existing vertigo but had not experienced any issues in eight months, she had 4 attacks of vertigo since Shingrix. The patient mentioned vomiting again. The reporter did not consented to follow-up. The patient declined to proceed with Safety report.   The patient implied flu like symptoms were resolved at the time of reporting, but unable to fully clarify during call. Therefore leaving outcome blank on those events.
Pharmacist failed to dilute the Covid19 Pfizer pediatric age 5-11 vaccine.  Pt received 0.2ml of undiluted vaccine. The pharmacist on duty realized her mistake and called the patient's mom shortly thereafter. The patient did not experience any immediate symptoms, but did have a fever of 101.8 the following day that resolved on its own without the use of medication. He did also experience fatigue, malaise and loss of appetite on 1/30/22 (the day after the error), but felt well the next day and was able to attend school.
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. Between 14-SEP-2018 and 17-SEP-2018, the patient was vaccinated with an improperly stored dose of VARIVAX lot # R006752, expiration date 06-MAR-2020 for prophylaxis. Sterile diluent (manufacturer unknown) was stored properly. The vaccine underwent a temperature excursion of -9 to 8 degrees Celsius for 21 hours and 35 minutes. There was no previous temperature excursion. The digital data logger was involved. No adverse effects were reported. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1809USA008086.
Pt(I) report swelling, redness, and warmth at the injection site was first noticed in the morning at 6:30 am on 12/24/2020 currently 2.5 inches by 1 5/8 inches. Pt has history of hives. Hive type rash noted on inside of right arm. Hive do not itch.
Client was given Pfizer vaccine at age 13.  No adverse reaction after vaccination given.  Telephone call to client and he reported he did very well with vaccine.  Informed him I would need to speak with his father regarding getting the dose incorrectly at his age and he collected my name and telephone number for his dad to call when off of work.  Telephone call to client's dad later and discussed the incorrect vaccination given.  Dad was wanting his son to finish the series.  Notified dad after speaking with our Medical Director the guidance was to not proceed with the second dose until approved through EUA.
Patient received vaccine and fainted shortly after administration. Patient was taken to the Emergency Department for further evaluation.  Patient stated she has had similar reaction from previous vaccinations.
Redness, warmth, inflammation at injection site. BENADRYL and prednisone ordered.
Itching, hives and feeling as though throat was swelling.  She took Benadryl at onset, then Benadryl at bedtime, which relieved symptoms until the next day when they returned and she checked in to the ER dept and received a Decadron injection which relieved symptoms within a couple of hours.
patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) in a 20-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided.  It was reported that, there was no power outages that would have impacted the Moderna vaccine. However, the healthcare professional reiterates that because her facility was unable to download the digital data logger, they needed to treat this issue as a temperature excursion. The data logger was unable to download for the months of Dec-2021, Jan-2022, and Feb-2022. They were filling out a temperature excursion assessment with the state at this time. It was also reported that, no adverse reactions were reported by the patient.  No treatment medication was provided.
Flu like symptoms; sick two days; This is a spontaneous report from a contactable consumer or other non hcp. This consumer reported that a 60-years-old female patient received bnt162b2 (BNT162B2, Formulation: Solution for injection, Batch/Lot number: EL0142), via an unspecified route of administration, administered in Arm on 15Jan2021 as 1ST DOSE, SINGLE DOSE for covid-19 immunisation. Medical history included covid-19 from Mar2020. Concomitant medications were not reported. On an unspecified date in Jan2021, the patient experienced sick two days and on an unspecified date, the patient had flu like symptoms. Caller said she was taking Advil, clarified later to being generic Ibuprofen made by Assure. She said she thinks now that she was not supposed to take any, but she took three Advil/generic Ibuprofen every 6 hours, 200mg each. generic Ibuprofen UPC: Unknown, barcode was not on the bottle and the outer package was discarded. LOT: S200302, EXP Nov2022. Caller says after she got the first dose of the vaccine in two days, she recovered from COVID or flu symptoms. It was reported that caller was a certified dental assistant who had a Sars-Cov-2 infection in Mar2020. She received her first dose of Pfizer-Biontech Covid19 vaccine 15Jan2021 and she was due to receive the second dose this Friday 05Feb2021. First dose of the Pfizer 15Jan2021-the only reason she was calling this late-my next one is on Friday-possibly not getting the second vaccine if you had the first dose and previous COVID infection- didn't test positive for it in March and antibodies in March. Consumer says she had her first dose of the Pfizer COVID-19 vaccine 15Jan2021. She says she had COVID last Mar, and after she had the first dose of the COVID-19 vaccine she was sick for two days after, sicker than when she had COVID last year, with flu like symptoms. Pfizer COVID-19 vaccine: Caller says she got her first dose of the COVID-19 vaccine on 15Jan2021 and she was down and out for two days, it was like having COVID again and her husband thinks this was worse and that she was sicker than when she had COVID. She says she was supposed to get the second dose on Friday, but she doesn't want to. Caller says she did have an antibody test before she had the vaccine, in April last year and the results were positive antibody test for SARS. She says that she got a call afterwards from the health department that said that she had had COVID. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on Apr2020. The patient was recovered from the events on an unspecified date in 2021.  Follow-up attempts completed. No further information expected.
Had variavax vaccine on 5/5/2008 p.m. on right SQ of arm developed sweeling, tenderness and pain at the sire 5x5 sweeling.Saw MD on 5/7/08 p.m.cellulitis , Keflex 250 mg qid for 7 days.
Brain fog; Fatigue; This is a spontaneous report received from a contactable consumer (patient) via COVID-19 Adverse Event Self-Reporting Solution (COVAES). A 28-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown), via an unspecified route of administration on 30Mar2021, (at the age of 28 years old), as a single dose for COVID-19 immunization.  Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Medical history and concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination.  The patient experienced brain fog and fatigue on 30Mar2021. Details were as follows: on 30Mar2021, after getting vaccination (Tuesday), the patient experienced brain fog and fatigue; this was noted as lasting through Saturday. The other unspecified symptoms had resolved. The events did not result in doctor or other healthcare professional office or clinic visit, emergency room or department or urgent care. Since the vaccination, the patient underwent a COVID test on 02Apr2021 and the results were unknown and pending. The clinical outcome of brain fog and fatigue was unknown.   No follow-up attempts are needed; information about lot number cannot be obtained.
Facial swelling, slurred speech, taste in mouth (medicine like), heart palpitations, rash to chest and face.
Seen 9/29/11 office visit with vesicle rash 1 week after varicella vaccine on 9/22/11. Approx 15-20 lesions, increased number lesions to 60-80 by parental report on 10/2/11. Positive lesion for varicella.
Large hive, like a welt, developed at the site of the flu shot.  He woke up with it, so it happened over night.
Patient felt light headed and sat on the ground. After a moment of sitting on the ground the patient passed out and hit her head. EMS was called and patient was assessed. Patient never lost consciousness. EMS was going to escort the patient to her vehicle, but along the way she passed out again. Patient was then transported to the hospital via ambulance.
Information has been received from a physician concerning a patient who on an unspecified date received the second dose of ROTATEQ (dose and lot # not reported) through oral administration. On 11-FEB-2010, the patient received the third dose of ROTATEQ (dose and lot # not reported) through oral administration. The physician reported that the patient spit out or regurgitated his second and third dose of ROTATEQ. No adverse effect reported. Follow-up information was received from the physician concerning this 18 week old male with no medical history, concurrent condition or illness at the time of vaccination who on 04-NOV-2009 received the second dose of ROTATEQ (lot # not reported) and spit it out. On 11-FEB-2010, the patient received the third dose of ROTATEQ (lot # 664649/1083Y) and vomited a few seconds after taking the vaccine. Subsequently the patient recovered. No further information was not available.
Narrative:  39 yo MALE p/w multiple complaints after taking the Covid vaccine 2 weeks ago. Patient has shortness of breath, nausea, chills, generalized weakness and fatigue. Patient states that it's hard for him to go to work because he comes  home and goes to sleep and then he can sleep at nighttime. He has sweats at  nighttime which does not keep him awake. No chest pain or abdominal pain. No fever. No headaches. No cough. No treatment given in ED and not discharged on any medications. Received the 2nd dose as scheduled.
Resident tested positive with a rapid test 08/12/2021. No symptoms present so PCR collected and sent to Capstone. PCR returned 08/14/2021 and was positive. Resident has remained without symptoms currently.
tingling in the feet, progressed to tingling in the hands, now 13 days later experiencing muscle cramping and slight weakness in the extremities in addition to tingling/crawling sensation.
pt recvd vax for prophylaxis; p/ dose 2, exp fever of 101; chills, ha,rash & achy bones; pt required bed rest; resolved
Received 1st shot of Moderna vaccine for covid on 7/31/21 at a pharmacy. Received shot in left arm and was VERY painful and stung REAL bad. No arm issues prior to shot. After a couple days, my arm was still hurting real bad, thought it was just part of getting the shot, continued to hurt 2-3 wks later and noticed I couldn't lift a gallon jug with my left arm. I have had issues with my upper arm/shoulder ever since receiving the shot (weakness, range of motion, shooting pain). Have seen my regular doctor 2x, physical therapy, Ultrasound, xrays, cortisone shot, MRI, seen (ortho surgeon) 3x, he said MRI showed I have a tear in my rotator cuff.
patient reported redness & swelling, pain in injection site. Warm to touch patient advised to apply ice, take NSAID & diphenhydramine & to contact PCP if worsens.